Dysregulated Fc receptor function in active rheumatoid arthritis

Immunology Letters

Volumn 162, Issue 1, 2014, Pages 200-206

  Magnusson, Sofia E ^a   Wennerberg, Erik ^a   Matt, Peter ^a   Lindqvist, Ulla ^a   Kleinau, Sandra ^a  

^a UPPSALA UNIVERSITY   (Sweden)

Author keywords

Autoimmunity; Fc receptor; IgG; Monocyte; Rheumatoid arthritis; Tumor necrosis factor alpha

Indexed keywords

C REACTIVE PROTEIN; CD16 ANTIGEN; CD32 ANTIGEN; CD64 ANTIGEN; FC RECEPTOR; FC RECEPTOR IIB; ANTIGEN ANTIBODY COMPLEX; AUTOANTIBODY; FCGR2B PROTEIN, HUMAN; IMMUNOGLOBULIN G; TUMOR NECROSIS FACTOR;

ADULT; AGED; ARTICLE; BINDING AFFINITY; CELL SURFACE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ACTIVITY; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; HUMAN; HUMAN CELL; IMMUNOGLOBULIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MONOCYTE; PHENOTYPE; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN BLOOD LEVEL; PROTEIN CROSS LINKING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PURIFICATION; PROTEIN SECRETION; RHEUMATOID ARTHRITIS; ROSETTE FORMATION; VERY ELDERLY; ANTIGEN ANTIBODY COMPLEX; ARTHRITIS, RHEUMATOID; BLOOD; CASE CONTROL STUDY; IMMUNOLOGY; IMMUNOPHENOTYPING; LEUKOCYTE COUNT; METABOLISM; MIDDLE AGED; SECRETION (PROCESS);

ADULT; AGED; AGED, 80 AND OVER; ANTIGEN-ANTIBODY COMPLEX; ARTHRITIS, RHEUMATOID; AUTOANTIBODIES; CASE-CONTROL STUDIES; FEMALE; HUMANS; IMMUNOGLOBULIN G; IMMUNOPHENOTYPING; LEUKOCYTE COUNT; MALE; MIDDLE AGED; MONOCYTES; RECEPTORS, FC; RECEPTORS, IGG; TUMOR NECROSIS FACTORS;

EID: 84908270911     PISSN: 01652478     EISSN: 18790542     Source Type: Journal    
DOI: 10.1016/j.imlet.2014.08.016     Document Type: Article

References (43)

1. Tarkowski A., Nilsson L.A. Isotype-specific measurement of rheumatoid factor with reference to clinical features of rheumatoid arthritis. J Clin Lab Immunol 1983, 12:129-135.
2. Schellekens G.A., de Jong B.A., van den Hoogen F.H., van de Putte L.B., van Venrooij W.J. Citrulline is an essential constituent of antigenic determinants recognized by rheumatoid arthritis-specific autoantibodies. J Clin Invest 1998, 101:273-281.
3. Hulett M.D., Hogarth P.M. Molecular basis of Fc receptor function. Adv Immunol 1994, 57:1-127.
4. Kleinau S., Martinsson P., Heyman B. Induction and suppression of collagen-induced arthritis is dependent on distinct Fc gamma receptors. J Exp Med 2000, 191:1611-1616.
5. van Lent P.L., van Vuuren A.J., Blom A.B., Holthuysen A.E., van de Putte L.B., van de Winkel J.G., et al. Role of Fc receptor gamma chain in inflammation and cartilage damage during experimental antigen-induced arthritis. Arthritis Rheum 2000, 43:740-752.
6. Diaz de Stahl T., Andren M., Martinsson P., Verbeek J.S., Kleinau S. Expression of FcγRIII is required for development of collagen-induced arthritis. Eur J Immunol 2002, 32:2915-2922.
7. Ioan-Facsinay A., de Kimpe S.J., Hellwig S.M., van Lent P.L., Hofhuis F.M., van Ojik H.H., et al. FcgammaRI (CD64) contributes substantially to severity of arthritis, hypersensitivity responses, and protection from bacterial infection. Immunity 2002, 16:391-402.
8. Tan Sardjono C., Mottram P.L., van de Velde N.C., Powell M.S., Power D., Slocombe R.F., et al. Development of spontaneous multisystem autoimmune disease and hypersensitivity to antibody-induced inflammation in Fcgamma receptor IIa-transgenic mice. Arthritis Rheum 2005, 52:3220-3229.
9. Thorvaldson L., Fuchs D., Magnusson S., Kleinau S. IgG immune complex-binding in macrophages from arthritis-susceptible and arthritis-resistant mice following collagen type II immunization. Scand J Immunol 2006, 63:347-354.
10. Nieto A., Caliz R., Pascual M., Mataran L., Garcia S., Martin J. Involvement of Fcgamma receptor IIIA genotypes in susceptibility to rheumatoid arthritis. Arthritis Rheum 2000, 43:735-739.
11. Morgan A.W., Griffiths B., Ponchel F., Montague B.M., Ali M., Gardner P.P., et al. Fcgamma receptor type IIIA is associated with rheumatoid arthritis in two distinct ethnic groups. Arthritis Rheum 2000, 43:2328-2334.
12. Morgan A.W., Barrett J.H., Griffiths B., Subramanian D., Robinson J.I., Keyte V.H., et al. Analysis of Fcgamma receptor haplotypes in rheumatoid arthritis: FCGR3A remains a major susceptibility gene at this locus, with an additional contribution from FCGR3B. Arthritis Res Ther 2006, 8(1). R5.
13. Chen J.Y., Wang C.M., Wu J.M., Ho H.H., Luo S.F. Association of rheumatoid factor production with FcgammaRIIIa polymorphism in Taiwanese rheumatoid arthritis. Clin Exp Immunol 2006, 144:10-16.
14. Wijngaarden S., van Roon J.A., Bijlsma J.W., van de Winkel J.G., Lafeber F.P. Fcgamma receptor expression levels on monocytes are elevated in rheumatoid arthritis patients with high erythrocyte sedimentation rate who do not use anti-rheumatic drugs. Rheumatology (Oxford) 2003, 42:681-688.
15. Blom A.B., Radstake T.R., Holthuysen A.E., Sloetjes A.W., Pesman G.J., Sweep F.G., et al. Increased expression of Fcgamma receptors II and III on macrophages of rheumatoid arthritis patients results in higher production of tumor necrosis factor alpha and matrix metalloproteinase. Arthritis Rheum 2003, 48:1002-1014.
16. Magnusson S.E., Engstrom M., Jacob U., Ulfgren A.K., Kleinau S. High synovial expression of the inhibitory FcgammaRIIb in rheumatoid arthritis. Arthritis Res Ther 2007, 9:R51.
17. Prokopec K.E., Rhodiner M., Matt P., Lindqvist U., Kleinau S. Down regulation of Fc and complement receptors on B cells in rheumatoid arthritis. Clin Immunol 2010, 137:322-329.
18. Heurkens A.H., Westedt M.L., Breedveld F.C., Jonges E., Cats A., Stijnen T., et al. Uptake and degradation of soluble aggregates of IgG by monocytes of patients with rheumatoid arthritis: relation to disease activity. Ann Rheum Dis 1991, 50:284-289.
19. Malaise M.G., Franchimont P., Houssier C., Closset J., Hennen G., Mahieu P.R. In vitro studies on the Fc-receptor function of mononuclear phagocytes in rheumatoid arthritis: relation between the Fc-receptor blockade and the concanavalin A-binding capacity of autologous immunoglobulin G. J Clin Immunol 1986, 6:442-456.
20. Miyata M., Sato Y., Kasukawa R. IgG 1 subclass specificity for IgG rheumatoid factors in patients with rheumatoid arthritis. J Rheumatol 1999, 26:1436-1438.
21. Kiely P.D., Helbert M.R., Miles J., Oliveira D.B. Immunosuppressant effect of gold on IgG subclasses and IgE; evidence for sparing of Th2 responses. Clin Exp Immunol 2000, 120:369-374.
22. Cook A.D., Mackay I.R., Cicuttini F.M., Rowley M.J. IgG subclasses of antibodies to type II collagen in rheumatoid arthritis differ from those in systemic lupus erythematosus and other connective tissue diseases. J Rheumatol 1997, 24:2090-2096.
23. Bruhns P., Iannascoli B., England P., Mancardi D.A., Fernandez N., Jorieux S., et al. Specificity and affinity of human Fcgamma receptors and their polymorphic variants for human IgG subclasses. Blood 2009, 113:3716-3725.
24. Arnett F.C., Edworthy S.M., Bloch D.A., McShane D.J., Fries J.F., Cooper N.S., et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988, 31:315-324.
25. Pricop L., Redecha P., Teillaud J.L., Frey J., Fridman W.H., Sautes-Fridman C., et al. Differential modulation of stimulatory and inhibitory Fc gamma receptors on human monocytes by Th1 and Th2 cytokines. J Immunol 2001, 166:531-537.
26. Schmidt R.E., Gessner J.E. Fc receptors and their interaction with complement in autoimmunity. Immunol Lett 2005, 100:56-67.
27. Wijngaarden S., van de Winkel J.G., Jacobs K.M., Bijlsma J.W., Lafeber F.P., van Roon J.A. A shift in the balance of inhibitory and activating Fcgamma receptors on monocytes toward the inhibitory Fcgamma receptor IIb is associated with prevention of monocyte activation in rheumatoid arthritis. Arthritis Rheum 2004, 50:3878-3887.
28. Meyer P.W., Hodkinson B., Ally M., Musenge E., Wadee A.A., Fickl H., et al. Circulating cytokine profiles and their relationships with autoantibodies, acute phase reactants, and disease activity in patients with rheumatoid arthritis. Mediators Inflamm 2010, 2010:158514.
29. Yilmaz-Elis A.S., Ramirez J.M., Asmawidjaja P., van der Kaa J., Mus A.M., Brem M.D., et al. FcgammaRIIb on myeloid cells rather than on B cells protects from collagen-induced arthritis. J Immunol 2014, 192:5540-5547.
30. Mancardi D.A., Albanesi M., Jonsson F., Iannascoli B., Van Rooijen N., Kang X., et al. The high-affinity human IgG receptor FcgammaRI (CD64) promotes IgG-mediated inflammation, anaphylaxis, and antitumor immunotherapy. Blood 2013, 121:1563-1573.
31. Torsteinsdottir I., Arvidson N.G., Hallgren R., Hakansson L. Monocyte activation in rheumatoid arthritis (RA): increased integrin, Fc gamma and complement receptor expression and the effect of glucocorticoids. Clin Exp Immunol 1999, 115:554-560.
32. Hepburn A.L., Mason J.C., Davies K.A. Expression of Fcgamma and complement receptors on peripheral blood monocytes in systemic lupus erythematosus and rheumatoid arthritis. Rheumatology (Oxford) 2004, 43:547-554.
33. Bunescu A., Seideman P., Lenkei R., Levin K., Egberg N. Enhanced Fcgamma receptor I, alphaMbeta2 integrin receptor expression by monocytes and neutrophils in rheumatoid arthritis: interaction with platelets. J Rheumatol 2004, 31:2347-2355.
34. Laurent L., Clavel C., Lemaire O., Anquetil F., Cornillet M., Zabraniecki L., et al. Fcgamma receptor profile of monocytes and macrophages from rheumatoid arthritis patients and their response to immune complexes formed with autoantibodies to citrullinated proteins. Ann Rheum Dis 2011, 70:1052-1059.
35. Wenink M.H., Santegoets K.C., Roelofs M.F., Huijbens R., Koenen H.J., van Beek R., et al. The inhibitory Fc gamma IIb receptor dampens TLR4-mediated immune responses and is selectively up-regulated on dendritic cells from rheumatoid arthritis patients with quiescent disease. J Immunol 2009, 183:4509-4520.
36. Kawanaka N., Yamamura M., Aita T., Morita Y., Okamoto A., Kawashima M., et al. CD14+, CD16+ blood monocytes and joint inflammation in rheumatoid arthritis. Arthritis Rheum 2002, 46:2578-2586.
37. Rousset F., Garcia E., Defrance T., Peronne C., Vezzio N., Hsu D.H., et al. Interleukin 10 is a potent growth and differentiation factor for activated human B lymphocytes. Proc Natl Acad Sci USA 1992, 89:1890-1893.
38. Perez L., Orte J., Brieva J.A. Terminal differentiation of spontaneous rheumatoid factor-secreting B cells from rheumatoid arthritis patients depends on endogenous interleukin-10. Arthritis Rheum 1995, 38:1771-1776.
39. Aloulou M., Ben Mkaddem S., Biarnes-Pelicot M., Boussetta T., Souchet H., Rossato E., et al. IgG1 and IVIg induce inhibitory ITAM signaling through FcgammaRIII controlling inflammatory responses. Blood 2012, 119:3084-3096.
40. Flesch B.K., Voge K., Henrichs T., Neppert J. Fcgamma receptor-mediated immune phagocytosis depends on the class of FcgammaR and on the immunoglobulin-coated target cell. Vox Sang 2001, 81:128-133.
41. Kumpel B.M., Beliard R., Brossard Y., Edelman L., de Haas M., Jackson D.J., et al. Section 1C: assessment of the functional activity and IgG Fc receptor utilisation of 64 IgG Rh monoclonal antibodies. Coordinator's report. Transfus Clin Biol 2002, 9:45-53.
42. Dale B.M., Traum D., Erdjument-Bromage H., Tempst P., Greenberg S. Phagocytosis in macrophages lacking Cbl reveals an unsuspected role for Fc gamma receptor signaling and actin assembly in target binding. J Immunol 2009, 182:5654-5662.
43. Lu Y.C., Yeh W.C., Ohashi P.S. LPS/TLR4 signal transduction pathway. Cytokine 2008, 42:145-151.